The Library
Browse by Department at the University of Warwick
Up a level |
Number of items: 25.
A
Afshar, Mehran, Al-Alloosh , F., Pirrie, S., Rowan, C., James, Nicholas D. and Porfiri, E. (2015) Predictive factors for response to abiraterone in metastatic castration refractory prostate cancer. Anticancer Research, 35 (2). pp. 1057-1063. ISSN 0250-7005.
Afshar, Mehran, Evison, Felicity, James, Nicholas D. and Patel, Prashant (2015) Shifting paradigms in the estimation of survival for castration-resistant prostate cancer : A tertiary academic center experience. Urologic Oncology: Seminars and Original Investigations, 33 (8). 338.e1-338.e7. doi:10.1016/j.urolonc.2015.05.003 ISSN 1078-1439.
B
Bahl, Amit, Masson, Susan, Malik, Zafar, Birtle, Alison J., Sundar, Santhanam, Jones, Rob J., James, Nicholas D., Mason, Malcolm D., Kumar, Satish, Bottomley, David, Lydon, Anna, Chowdhury, Simon, Wylie, James and de Bono, Johann S. (2015) Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279). BJU International, 116 (6). pp. 880-887. doi:10.1111/bju.13069 ISSN 1464-1603.
Boyce, M., Gullien, R., Parashar, D. and Taylor, K. (2015) Comparing the use and interpretation of PGMI scoring to assess the technical quality of screening mammograms in the UK and Norway. Radiographics, 21 (4). pp. 342-347. doi:10.1016/j.radi.2015.05.006 ISSN 0271-5333.
Bryan, Richard T., Regan, H. L., Pirrie, S. J., Devall, A. J., Cheng, Kar K. , Zeegers, Maurice P., James, Nicholas D., Knowles, M. A. and Ward, D. G. (2015) Protein shedding in urothelial bladder cancer : prognostic implications of soluble urinary EGFR and EpCAM. British Journal of Cancer, 112 (6). pp. 1052-1058. doi:10.1038/bjc.2015.21 ISSN 0007-0920.
C
Cathomas, Richard, De Santis, Maria and Galsky, Matthew D. (2015) First-line treatment of metastatic disease : Cisplatin-ineligible patients. Hematology/Oncology Clinics of North America, Volume 29 (Number 2). pp. 329-340. doi:10.1016/j.hoc.2014.10.006 ISSN 0889-8588.
Cathomas , R., De Santis, Maria and Galsky, M. D. (2015) First line treatment of metastatic disease : Cisplatin-Ineligible patients. In: Bellmunt, Joaquim , (ed.) Bladder Cancer, an issue of Hematology/Oncology Clinics of North America. Amsterdam ; Oxford: Elsevier. ISBN 9780323359764
Connolly, Stephen S., Raja, Aditya, Stunell, Helen, Parashar, D., Upponi, Sara, Warren, Anne Y., Gnanapragasam, Vincent J. and Eisen, Tim (2015) Diagnostic accuracy of preoperative computed tomography used alone to detect lymph-node involvement at radical nephrectomy. Scandinavian Journal of Urology, 49 (2). pp. 142-148. doi:10.3109/21681805.2014.969307 ISSN 2168-1805.
Connolly, Stephen S., Raja, Aditya, Stunell, Helen, Parashar, D., Upponi, Sara, Warren, Anne Y., Gnanapragasam, Vincent J. and Eisen, Tim (2015) Diagnostic accuracy of preoperative computed tomography used alone to detect lymph-node involvement at radical nephrectomy. Scandinavian Journal of Urology, 49 (2). pp. 142-148. doi:10.3109/21681805.2014.969307 ISSN 2168-1805.
D
De Santis, Maria, Bachner, Mark, Cerveny, M., Kametriser, G., Steininger, T., Konigsberg, R., Schratter-Sehn, A., Sedlmayer, F. and Dittrich, C. (2015) Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery : a phase I trial. Annals of Oncology, Volume 25 (Number 9). pp. 1789-1794. doi:10.1093/annonc/mdu209 ISSN 0923-7534.
De Santis, Maria and Galsky, Matthew D. (2015) Treatment of poor risk patients. In: Bladder cancer : diagnosis and clinical management. Oxford : Wiley-Blackwell Publishing Ltd.. ISBN 9781118674840
Dev, Harveer S., Wiklund, Peter, Patel, Vipul, Parashar, D., Palmer, Kenneth, Nyberg, Tommy, Skarecky, Doug, Neal, David E., Ahlering, Tom and Sooriakumaran, Prasanna (2015) Surgical margin length and location affect recurrence rates after robotic prostatectomy. Urologic Oncology: Seminars and Original Investigations, 33 (3). 109.e7-109.e13. doi:10.1016/j.urolonc.2014.11.005 ISSN 1078-1439.
E
(2015) SWITCH : A randomised, sequential, open-label study to evaluate the efficacy and safety of Sorafenib-sunitinib versus Sunitinib-sorafenib in the treatment of metastatic renal cell cancer. European Urology, 68 (5). pp. 837-848. doi:10.1016/j.eururo.2015.04.017 ISSN 0302-2838.
F
Fakhrejahani, Farhad, Tomita, Yusuke, Maj-Hes, Agnes, Trepel, Jane B., De Santis, Maria and Apolo, Andrea B. (2015) Immunotherapies for bladder cancer : a new hope. Current Opinion in Urology, 25 (6). pp. 504-509. doi:10.1097/MOU.0000000000000213 ISSN 0963-0643.
Fizazi, Karim, Abrahamsson, Per-Anders, Ahlgren, Goran, Bellmunt, Joaquim, Castellano, Daniel, Culine, Stephane, de Wit, Ronald, Gillessen, Silke, Gschwend, Juergen E., Hamdy, Freddie, James, Nicholas D., McDermott, Raymond, Miller, Kurt, Wiegel, Thomas, Wirth, Manfred and Tombal, Bertrand (2015) Achievements and perspectives in prostate cancer phase 3 trials from genitourinary research groups in Europe : introducing the prostate cancer consortium in Europe. European Urology, 67 (5). pp. 904-912. doi:10.1016/j.eururo.2014.08.076 ISSN 0302-2838.
G
(2015) Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Annals of Oncology, 26 (8). pp. 1589-1604. doi:10.1093/annonc/mdv257 ISSN 0923-7534.
J
James, Nicholas D., Sydes, Matthew R., Clarke, Noel W., Mason, Malcolm D., Dearnaley, David P. and Spears, Melissa R. (2015) Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE) : survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. The Lancet, 387 (10024). pp. 1163-1177. doi:10.1016/S0140-6736(15)01037-5 ISSN 0140-6736.
K
Kitchen, Mark O., Bryan, Richard T., Haworth, Kim E., Emes, Richard D., Luscombe, Christopher, Gommersall, Lyndon, Cheng, Kar K., Zeegers, Maurice P., James, Nicholas D., Devall, Adam J., Fryer, Anthony A. and Farrell, William E. (2015) Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer. PLoS One, 10 (9). pp. 1-12. e0137003. doi:10.1371/journal.pone.0137003 ISSN 1932-6203.
M
McDonald, F., Waters, R., Gulliford, S., Hall, E., James, Nicholas D. and Huddart, R. A. (2015) Defining bowel dose volume constraints for bladder radiotherapy treatment planning. Clinical Oncology, Volume 27 (Number 1). pp. 22-29. doi:10.1016/j.clon.2014.09.016 ISSN 0936-6555.
Mulders, Peter F., De Santis, Maria , Powles, Thomas and Fizazi, Karim (2015) Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy. Cancer Immunology, Immunotherapy, Volume 64 (Number 6). pp. 655-663. doi:10.1007/s00262-015-1707-3 ISSN 0340-7004.
P
Panagiotopoulou, Ioanna G., Parashar, D., Qasem, Eyas, Mezher-Sikafi, Rasha, Parmar, Jitesh, Wells, Alan D., Bajwa, Farrukh M., Menon, Madhav and Jephcott, Catherine R. (2015) Neoadjuvant long-course chemoradiotherapy for rectal cancer : does time to surgery matter? International Surgery, 100 (6). pp. 968-973. doi:10.9738/INTSURG-D-14-00192.1 ISSN 0020-8868.
Parashar, D., Bowden, Jack, Starr, Colin, Wernisch, Lorenz and Mander, Adrian (2015) Type I error control in biomarker-stratified clinical trials. In: 3rd International Clinical Trials Methodology Conference, Glasgow SECC, UK, 16-17 Nov 2015. Published in: Trials, 16 (Suppl 2). O84. doi:10.1186/1745-6215-16-S2-O84 ISSN 1745-6215.
S
(2015) Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3βpT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994) : an intergroup, open-label, randomised phase 3 trial. The Lancet Oncology, Volume 16 (Number 1). pp. 76-86. doi:10.1016/S1470-2045(14)71160-X ISSN 1470-2045.
V
Vivekanandan, Sindu, Breene, Richard, Ramanujachar, Ramya, Traunecker, Heidi, Pizer, Barry, Gaze, Mark N., Saran, Frank, Thorp, Nicky, English, Martin, Wheeler, Kate AH, Michalski, Antony, Walker, David A., Saunders, Daniel, Cowie, Fiona, Cameron, Alison, Picton, Susan V, Parashar, D., Horan, Gail and Williams, Michael V. (2015) The UK experience of a treatment strategy for pediatric metastatic medulloblastoma comprising intensive induction chemotherapy, hyperfractionated accelerated radiotherapy and response directed high dose myeloablative chemotherapy or maintenance chemotherapy (Milan Strategy). Pediatric Blood & Cancer, 62 (12). pp. 2132-2139. doi:10.1002/pbc.25663 ISSN 1545-5009.
Y
Young, Annie M. (2015) Review : Quality of life and resilience related to chemotherapy-induced peripheral neuropathy in patients post treatment with platinums and taxanes. Journal of Research in Nursing, 20 (5). pp. 399-400. ISSN 1744-9871 doi:10.1177/1744987115574638